Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
32.85B | 32.23B | 29.45B | 28.95B | 26.13B | Gross Profit |
12.27B | 11.21B | 9.71B | 9.47B | 7.88B | EBIT |
5.07B | 4.87B | 3.34B | 5.72B | 1.59B | EBITDA |
6.13B | 5.83B | 4.21B | 6.83B | 2.20B | Net Income Common Stockholders |
3.94B | 3.75B | 2.48B | 4.55B | 5.15B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.64B | 5.82B | 4.88B | 5.33B | 5.39B | Total Assets |
40.36B | 40.94B | 39.15B | 40.26B | 41.09B | Total Debt |
7.81B | 8.74B | 8.55B | 6.48B | 7.12B | Net Debt |
3.50B | 4.85B | 4.39B | 2.32B | 3.84B | Total Liabilities |
25.30B | 26.79B | 25.88B | 24.30B | 25.09B | Stockholders Equity |
14.49B | 13.41B | 12.78B | 15.58B | 15.69B |
Cash Flow | Free Cash Flow | |||
3.83B | 3.52B | 525.00M | 2.51B | 999.00M | Operating Cash Flow |
4.67B | 4.29B | 1.29B | 3.33B | 1.69B | Investing Cash Flow |
-725.00M | -1.61B | 981.00M | 2.31B | 6.76B | Financing Cash Flow |
-3.33B | -2.90B | -2.39B | -4.97B | -8.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $190.65B | 18.85 | 14.40% | 1.61% | -1.04% | 9.00% | |
76 Outperform | $101.96B | 25.72 | 28.23% | 1.07% | 3.16% | 5.77% | |
74 Outperform | $205.77B | 32.15 | 27.62% | 0.58% | -32.60% | -28.55% | |
72 Outperform | $63.06B | 28.21 | 9.66% | 1.88% | 10.29% | 22.72% | |
69 Neutral | $29.98B | 33.65 | 26.22% | 1.89% | -11.28% | -23.69% | |
68 Neutral | $135.33B | 24.56 | 33.10% | 2.07% | 5.05% | 2.73% | |
62 Neutral | $8.16B | 12.85 | 0.64% | 3.04% | 3.83% | -15.83% |